12:00 AM
Sep 22, 2014
 |  BC Week In Review  |  Company News  |  Other News

Bayer pharmaceuticals, other news

Bayer said it will focus on its life science businesses and spin out its material sciences division, Bayer MaterialScience, into a separate publicly listed company in the next 12-18 months. The pharma said the major reason for the split is to give Bayer MaterialScience direct access to capital, noting that "this access can no longer be adequately ensured within the...

Read the full 276 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >